IL158730A0 - Novel expression vectors and uses thereof - Google Patents

Novel expression vectors and uses thereof

Info

Publication number
IL158730A0
IL158730A0 IL15873002A IL15873002A IL158730A0 IL 158730 A0 IL158730 A0 IL 158730A0 IL 15873002 A IL15873002 A IL 15873002A IL 15873002 A IL15873002 A IL 15873002A IL 158730 A0 IL158730 A0 IL 158730A0
Authority
IL
Israel
Prior art keywords
expression vectors
novel expression
novel
vectors
expression
Prior art date
Application number
IL15873002A
Other languages
English (en)
Original Assignee
Fit Biotech Oy Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20010922A external-priority patent/FI116851B/fi
Application filed by Fit Biotech Oy Plc filed Critical Fit Biotech Oy Plc
Publication of IL158730A0 publication Critical patent/IL158730A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL15873002A 2001-05-03 2002-05-03 Novel expression vectors and uses thereof IL158730A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20010922A FI116851B (fi) 2001-05-03 2001-05-03 Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
US10/138,098 US7498314B2 (en) 2001-05-03 2002-05-03 Expression vectors and uses thereof
PCT/FI2002/000379 WO2002090558A1 (en) 2001-05-03 2002-05-03 Novel expression vectors and uses thereof

Publications (1)

Publication Number Publication Date
IL158730A0 true IL158730A0 (en) 2004-05-12

Family

ID=26161168

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15873002A IL158730A0 (en) 2001-05-03 2002-05-03 Novel expression vectors and uses thereof
IL158730A IL158730A (en) 2001-05-03 2003-11-03 Expression vectors based upon the e2 protein of the bovine papilloma virus type 1, uses thereof and methods for the preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158730A IL158730A (en) 2001-05-03 2003-11-03 Expression vectors based upon the e2 protein of the bovine papilloma virus type 1, uses thereof and methods for the preparation thereof

Country Status (23)

Country Link
EP (1) EP1390516B1 (pt)
JP (1) JP5016779B2 (pt)
CN (1) CN100430482C (pt)
AP (1) AP2368A (pt)
AT (1) ATE426035T1 (pt)
AU (1) AU2002253198B2 (pt)
BR (1) BRPI0209416A8 (pt)
CA (1) CA2446260C (pt)
CZ (1) CZ301691B6 (pt)
DE (1) DE60231613D1 (pt)
DK (1) DK1390516T3 (pt)
EA (1) EA009388B1 (pt)
EE (1) EE05691B1 (pt)
ES (1) ES2324095T3 (pt)
HK (1) HK1063486A1 (pt)
HU (1) HU227667B1 (pt)
IL (2) IL158730A0 (pt)
MX (1) MXPA03009978A (pt)
NZ (1) NZ529327A (pt)
PL (1) PL206097B1 (pt)
SI (1) SI1390516T1 (pt)
SK (1) SK287471B6 (pt)
WO (1) WO2002090558A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003292280A1 (en) * 2002-12-20 2004-07-14 Strom & Gulliksson Ip Ab Vectors lacking an origin of replication functioning in mammalian cells and expressing growth factors
FI116068B (fi) * 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
WO2005117997A1 (en) * 2004-06-01 2005-12-15 The Ohio State University Ligands having metal binding ability and targeting properties
EP2047861B1 (en) * 2007-10-12 2019-07-31 Institut Pasteur Lentiviral gene transfer vectors suitable for iterative administration and their medicinal applications
BRPI0813194B8 (pt) 2007-08-03 2021-05-25 Centre Nat Rech Scient kit, partículas de vetor lentiviral, composição de vetores plasmídicos, antígeno derivado de hiv-1 quimérico, proteína de envelope de vsv-g, moléculas de ácido nucleico, composição imunogênica e uso de um vetor lentiviral
US9309493B2 (en) * 2009-03-27 2016-04-12 Eidgenoessische Technische Hochschule Zurich Salmonella enterica presenting C. jejuni N-glycan or derivatives thereof
EP2928910B1 (en) 2012-12-06 2019-09-04 PIN Pharma, Inc. Treatment of inflammation, autoimmune, and neurodegenerative disorders with immunosuppressive tat derivative polypeptides
CN107344962B (zh) * 2016-05-04 2021-03-02 中国科学院微生物研究所 阻遏蛋白、调控元件组和基因表达调控系统及其构建方法
WO2018185110A1 (en) 2017-04-03 2018-10-11 Fit Biotech Oy Novel expression vectors and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
ATE199570T1 (de) * 1996-08-16 2001-03-15 Medical Res Council Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln

Also Published As

Publication number Publication date
JP5016779B2 (ja) 2012-09-05
DK1390516T3 (da) 2009-07-13
HK1063486A1 (en) 2004-12-31
NZ529327A (en) 2006-01-27
PL206097B1 (pl) 2010-06-30
WO2002090558A1 (en) 2002-11-14
MXPA03009978A (es) 2005-03-07
BRPI0209416A2 (pt) 2004-03-30
WO2002090558A9 (en) 2003-02-06
SK14692003A3 (sk) 2004-07-07
SK287471B6 (sk) 2010-11-08
HUP0304053A3 (en) 2004-10-28
SI1390516T1 (sl) 2009-08-31
EE05691B1 (et) 2013-12-16
EA200301207A1 (ru) 2004-08-26
CZ20033201A3 (en) 2004-05-12
EA009388B1 (ru) 2007-12-28
ATE426035T1 (de) 2009-04-15
CZ301691B6 (cs) 2010-05-26
AP2003002914A0 (en) 2003-12-31
HU227667B1 (en) 2011-11-28
IL158730A (en) 2010-06-16
AP2368A (en) 2012-02-27
CN100430482C (zh) 2008-11-05
PL367126A1 (en) 2005-02-21
CN1529758A (zh) 2004-09-15
DE60231613D1 (de) 2009-04-30
EE200300483A (et) 2004-04-15
CA2446260C (en) 2011-06-14
JP2004533247A (ja) 2004-11-04
CA2446260A1 (en) 2002-11-14
EP1390516B1 (en) 2009-03-18
ES2324095T3 (es) 2009-07-30
BRPI0209416A8 (pt) 2018-05-08
EP1390516A1 (en) 2004-02-25
HUP0304053A2 (hu) 2004-03-29
AU2002253198B2 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
EP1463742A4 (en) NEW PYRAZOLO AND PYRROLO PYRIMIDINES AND THEIR USES
EP1370249A4 (en) NEW DENDRITIC POLYMERS AND ITS BIOMEDICAL APPLICATIONS
GB0123278D0 (en) Labelled articles and uses thereof
EP1408978A4 (en) NOVEL PHENYLAMINO-PYRIMIDINES AND THEIR USE
AU7025201A (en) Expression vectors
PT1390516E (pt) Novos vectores de expressão e uso dos mesmos
TW509023U (en) Cosmetic case
IL154553A0 (en) Urocortin-iii and uses thereof
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
EP1410782A4 (en) COSMETIC PRODUCT
GB2376928B (en) Personal hoverplane having four tiltmotors
HUP0304053A3 (en) Novel expression vectors and uses thereof
EP1408985A4 (en) NEW PYRIDOPYRIMIDONE AND ITS USES
EP1390074A4 (en) NEW COMPOSITIONS AND USES THEREOF
PL370031A1 (en) Novel amylases and uses thereof
GB0008936D0 (en) Vectors
AU2002213398A1 (en) Expression vectors and uses thereof
AU2003291426A8 (en) Gp64-pseudotyped vectors and uses thereof
EP1367123A4 (en) NEUROTONIN AND ITS USE
HK1052469A1 (en) Cosmetics
GB0122803D0 (en) Vector
EP1395276A4 (en) STRUCTURALLY MODIFIED PEPTIDES AND THEIR USE
SG10201403662QA (en) Replikin peptides and uses thereof
IL159495A0 (en) Replikin peptides and uses thereof